Literature DB >> 26232326

PTEN gene polymorphisms and susceptibility to oral squamous cell carcinoma in a Chinese Han population.

Xu-Dong Yang1, Su-Feng Zhao1, Qian Zhang1, Wei Li1, Yu-Xin Wang1, Xiao-Wei Hong1, Qin-Gang Hu2.   

Abstract

The tumor suppressor gene phosphatase and tensin homologue (PTEN) plays a significant role in regulating cell growth, proliferation, and apoptosis. However, there are no data regarding the role of PTEN polymorphisms in the development of oral squamous cell carcinoma (OSCC). A hospital-based case-control study was conducted to investigate the potential association between PTEN polymorphisms and the risk of OSCC in a Chinese Han population. The study population comprised 201 patients with OSCC and 199 healthy controls. Seventeen single-nucleotide polymorphisms (SNPs) of PTEN were investigated and genotyped using Sequenom Mass ARRAY and iPLEX-MALDI-TOF technology. The observed genotype frequencies of these polymorphisms were in agreement with Hardy-Weinberg equilibrium in the control group (P > 0.05 for all). The heterozygous CT genotype was not associated with significantly increased risk for OSCC (OR = 0.89, 95 % CI = (0.55-1.42), P = 0.83), the TT genotype was not associated with increased risk for OSCC (OR = 1.01, 95 % CI = (0.58-1.74), P = 0.74) compared to the PTEN SNP rs1234224 homozygous CC genotype. Meanwhile, CT/TT variants were not associated with increased risk for OSCC compared with the CC genotype (OR = 0.93, 95 % CI = 0.60-1.44, P = 0.73). The T allele was not associated with significantly increased risk compared to the C allele (OR = 0.99, 95 % CI = 0.72-1.58, P = 0.69). Similar associations with the risk of OSCC were observed for the other genotypes of PTEN gene polymorphisms. There were no significant differences in the distribution of the genotype and allele frequencies of polymorphisms of the PTEN gene between the OSCC patients and controls in a Chinese Han population. Further studies are needed to clarify the specific roles of PTEN polymorphisms in the etiology of OSCC.

Entities:  

Keywords:  Oral squamous cell carcinoma; PTEN; Single-nucleotide polymorphism; Susceptibility

Mesh:

Substances:

Year:  2015        PMID: 26232326     DOI: 10.1007/s13277-015-3804-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  29 in total

1.  PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway.

Authors:  H Sun; R Lesche; D M Li; J Liliental; H Zhang; J Gao; N Gavrilova; B Mueller; X Liu; H Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

2.  Subtle variations in Pten dose determine cancer susceptibility.

Authors:  Andrea Alimonti; Arkaitz Carracedo; John G Clohessy; Lloyd C Trotman; Caterina Nardella; Ainara Egia; Leonardo Salmena; Katia Sampieri; William J Haveman; Edi Brogi; Andrea L Richardson; Jiangwen Zhang; Pier Paolo Pandolfi
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

Review 3.  Early diagnosis of oral cavity cancers.

Authors:  Prairie Neeley Robinson; Alan R Mickelson
Journal:  Otolaryngol Clin North Am       Date:  2006-04       Impact factor: 3.346

4.  Association between PTEN IVS4 polymorphism and development of colorectal cancer in a Turkish population.

Authors:  Emel Canbay; Ozlem T Kahraman; Dursun Bugra; Burcu Caykara; Mehmet Fatih Seyhan; Turker Bulut; Sumer Yamaner; Oguz Ozturk
Journal:  Expert Opin Ther Targets       Date:  2012-10-14       Impact factor: 6.902

5.  Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk.

Authors:  Meng Chen; Adrian Cassidy; Jian Gu; George L Delclos; Fan Zhen; Hushan Yang; Michelle A T Hildebrandt; Jie Lin; Yuanqing Ye; Robert M Chamberlain; Colin P Dinney; Xifeng Wu
Journal:  Carcinogenesis       Date:  2009-12       Impact factor: 4.944

Review 6.  PTEN: a new guardian of the genome.

Authors:  Y Yin; W H Shen
Journal:  Oncogene       Date:  2008-09-18       Impact factor: 9.867

7.  Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity.

Authors:  A Mavros; M Hahn; I Wieland; S Koy; O N Koufaki; K Strelocke; R Koch; G Haroske; H K Schackert; U Eckelt
Journal:  J Oral Pathol Med       Date:  2002-05       Impact factor: 4.253

Review 8.  Molecular biology of head and neck cancer: risks and pathways.

Authors:  Michael E Stadler; Mihir R Patel; Marion E Couch; David Neil Hayes
Journal:  Hematol Oncol Clin North Am       Date:  2008-12       Impact factor: 3.722

9.  HER2 Ile655Val and PTEN IVS4 polymorphisms in patients with breast cancer.

Authors:  Oguz Ozturk; Emel Canbay; Ozlem T Kahraman; M Fatih Seyhan; Fatih Aydogan; Varol Celik; Cihan Uras
Journal:  Mol Biol Rep       Date:  2012-10-21       Impact factor: 2.316

10.  KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression in Chinese patients with colorectal cancer.

Authors:  Chen Mao; Junhua Zhou; Zuyao Yang; Yafang Huang; Xinyin Wu; Hong Shen; Jinling Tang; Qing Chen
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

View more
  1 in total

1.  Expression and significance of PTEN and Claudin-3 in prostate cancer.

Authors:  Xinglong Ye; Lijing Zhao; Jing Kang
Journal:  Oncol Lett       Date:  2019-04-03       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.